Endo Pharmaceuticals Holdings (ENDP) Tops Q2 EPS by 8c; Trims FY Revenue Views
Tweet Send to a Friend
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q2 EPS of $1.27, $0.08 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
